A local event invites people to drop in and ask a PharmD about GLP-1 drugs. No location or details beyond the same-day timing.
Recap by typeshit. Post by Facebook on Facebook.
Osbourne says any medicine can be misused and connects Ozempic to the body image struggles he had when he was younger.
A one-line stock move for the maker of Mounjaro and Zepbound, with no reason given for the gain.
29:53
Journalist Scott Carney argues in favor of gray-market peptides. Only the title is available, so watch for his full reasoning and treat any health claims with caution.
The company announced exclusive manufacturing rights across its needle-free peptide products. Terms aren't given here.
Hermida shares that emerging research suggests GLP-1 medications could have effects beyond obesity and diabetes. A short post with few specifics.
A short Facebook post reports a recall of GLP-1 weight loss injections, without naming the product or the maker.
Loading…